Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Solas BioVentures, founded in 2015, is an early-stage venture capital firm based in Chattanooga, Tennessee. The firm focuses on the life sciences sector, with a global investment approach and assets under management that support investments ranging from $250,000 to $5 million.
Investing exclusively in the life sciences sector, Solas BioVentures targets early-stage opportunities in biopharmaceuticals, medical devices, and digital health. Their investment strategy encompasses seed, Series A, and Series B funding stages, aiming to support innovative solutions that improve patient outcomes.
Notable companies in Solas BioVentures' portfolio include Arrivo, Basking Biosciences, Cryosa, Dimension Bio, iNTERSHUNT, NXP, Phenomics Health, Stimdia, Vektor Medical, and VESALIO.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.